- Home
- COLL vs HGTY Comparison
COLL vs HGTY Comparison
Compare COLL & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- HGTY
- Stock Information
- Founded
- COLL 2002
- HGTY 1984
- Country
- COLL United States
- HGTY United States
- Employees
- COLL N/A
- HGTY N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- HGTY Specialty Insurers
- Sector
- COLL Health Care
- HGTY Finance
- Exchange
- COLL Nasdaq
- HGTY Nasdaq
- Market Cap
- COLL 910.2M
- HGTY 995.8M
- IPO Year
- COLL 2015
- HGTY N/A
- Fundamental
- Price
- COLL $29.05
- HGTY $8.70
- Analyst Decision
- COLL Strong Buy
- HGTY Hold
- Analyst Count
- COLL 5
- HGTY 3
- Target Price
- COLL $43.60
- HGTY $11.00
- AVG Volume (30 Days)
- COLL 438.9K
- HGTY 82.8K
- Earning Date
- COLL 05-08-2025
- HGTY 05-06-2025
- Dividend Yield
- COLL N/A
- HGTY N/A
- EPS Growth
- COLL 43.56
- HGTY 8.26
- EPS
- COLL 1.86
- HGTY 0.10
- Revenue
- COLL $631,449,000.00
- HGTY $1,200,038,000.00
- Revenue This Year
- COLL $20.00
- HGTY N/A
- Revenue Next Year
- COLL $3.93
- HGTY $35.16
- P/E Ratio
- COLL $15.63
- HGTY $88.66
- Revenue Growth
- COLL 11.41
- HGTY 19.98
- 52 Week Low
- COLL $27.28
- HGTY $8.30
- 52 Week High
- COLL $42.29
- HGTY $12.35
- Technical
- Relative Strength Index (RSI)
- COLL 43.65
- HGTY 29.53
- Support Level
- COLL $29.01
- HGTY $8.79
- Resistance Level
- COLL $30.53
- HGTY $9.18
- Average True Range (ATR)
- COLL 0.88
- HGTY 0.38
- MACD
- COLL -0.01
- HGTY -0.03
- Stochastic Oscillator
- COLL 20.97
- HGTY 14.55
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.